Thromb Haemost 2012; 107(06): 1189-1191
DOI: 10.1160/TH11-11-0788
Letters to the Editor
Schattauer GmbH

Dabigatran etexilate (Pradaxa®) for preventing warfarin-induced skin necrosis in a patient with severe protein C deficiency

Cedric Hermans
1   Hemostasis and Thrombosis Unit, Division of Adult Hematology, Cliniques Universitaires Saint-Luc, Brussels, Belgium
,
Stéphane Eeckhoudt
2   Hemostasis and Thrombosis Laboratory, Division of Biological Chemistry, Cliniques Universitaires Saint-Luc, Brussels, Belgium
,
Catherine Lambert
1   Hemostasis and Thrombosis Unit, Division of Adult Hematology, Cliniques Universitaires Saint-Luc, Brussels, Belgium
› Author Affiliations
Further Information

Publication History

Received: 14 November 2011

Accepted after major revision: 21 February 2012

Publication Date:
29 November 2017 (online)